Promising antitumor activity was observed in heavily pretreated patients with melanoma and gynecologic cancers without MUC18 preselection SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Multitude Therapeutics ...
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Multitude Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of ADC drugs, today announced interim results from its ...
Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and other advanced solid tumors without CD44v9 pre-selection SHANGHAI, Oct. 17, 2025 /PRNewswire/ -- ...
Hosted on MSN
Modern Warfare II’s Minimap Problem Explained
The minimap issue in Modern Warfare II continues to frustrate players, and here’s why. I break down the design flaws, what fans are asking for, and how fixing it could massively improve gameplay flow.
~ Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared to a propensity score-matched external ...
UniQure N.V. (NASDAQ:QURE) shares are trading higher Wednesday after the company announced positive topline results from Phase I/II study of AMT-130 in patients with Huntington’s Disease. What To Know ...
LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs ...
While some university administrations give in to their SJP protesters, and others fight back, the University of Rochester (UofR) in upstate New York simply denies that SJP exists on its campus. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback